Actinium Pharmaceuticals Inc. Is Being Looked Into By The Schall Law Firm For Violating Securities Related Laws And Shareholders Should Reach OutAccesswire • 09/04/24
Investors With Losses In Actinium Pharmaceuticals Inc Are Urged To Contact The Schall Law Firm About A Securities Fraud InquiryAccesswire • 09/03/24
The Schall Law Firm Is Looking Into Whether Actinium Pharmaceuticals Inc. Violated Securities Regulations And Stockholders Should Reach OutAccesswire • 09/02/24
Actinium Pharmaceuticals Inc May Have Committed Securities Related Infractions And Investors Are Invited To Participate In The Schall Law Firm's InquiryAccesswire • 09/01/24
Shareholders Who Have Been Affected By Actinium Pharmaceuticals Inc.'s Possible Securities Law Violations Should Join The Schall Law Firm's InvestigationAccesswire • 08/31/24
Actinium Pharmaceuticals Inc May Have Committed Securities Fraud And The Schall Law Firm Wants Impacted Investors To Reach Out About An InquiryAccesswire • 08/30/24
The Public Is Urged To Join The Schall Law Firm In Investigating Actinium Pharmaceuticals Inc. For Possible Securities Law ViolationsAccesswire • 08/29/24
An Inquiry Has Been Launched Into Whether Actinium Pharmaceuticals Inc Committed Securities Law Violations And The Schall Law Firm Seeks Investors' HelpAccesswire • 08/28/24
The Schall Law Firm Invites Actinium Pharmaceuticals Stakeholders To Participate In A Securities Fraud InvestigationAccesswire • 08/27/24
Shareholders In Actinium Pharmaceuticals Inc. Are Urged To Join The Schall Law Firm In An Inquiry Into Possible Securities Law InfractionsAccesswire • 08/26/24
The Schall Law Firm Is Investigating Actinium Pharmaceuticals Inc. For Potential Securities Fraud And Investors With Losses Are Encouraged To Take PartAccesswire • 08/25/24
The Schall Law Firm Is Investigating Actinium Pharmaceuticals Inc For Securities Fraud And Investors Are Encouraged To ParticipateAccesswire • 08/24/24
Actinium Pharmaceuticals Inc Is Being Looked Into By The Schall Law Firm For Possible Securities Law Violations And Stockholders Are Urged To Reach OutAccesswire • 08/23/24
Investors With Losses In Actinium Pharmaceuticals Inc Are Encouraged To Join An Investigation Into Securities Fraud With The Schall Law FirmAccesswire • 08/22/24
ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm Today!Accesswire • 08/22/24
Shareholders In Actinium Pharmaceuticals Inc Urged To Participate In A Securities Fraud Investigation With The Schall Law FirmAccesswire • 08/21/24
ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm Today!Accesswire • 08/21/24
Shareholders that lost money on Actinium Pharmaceuticals, Inc.(ATNM) should contact Levi & Korsinsky about Securities Fraud Investigation - ATNMAccesswire • 08/21/24
Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsGlobeNewsWire • 08/20/24
Stockholders With Losses In Actinium Pharmaceuticals Inc Urged To Participate In Fraud Investigation With The Schall Law FirmAccesswire • 08/20/24
ATNM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Today!Accesswire • 08/20/24
Did Actinium Pharmaceuticals, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ATNMAccesswire • 08/20/24
Investors With Losses In Actinium Pharmaceuticals Inc Can Join Fraud Investigation With The Schall Law FirmAccesswire • 08/19/24
ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Today!Accesswire • 08/19/24
An Investigation Has Commenced on Behalf of Actinium Pharmaceuticals, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your ATNM Losses.Accesswire • 08/19/24